Interpharma, the association of Switzerland’s research-based pharmaceutical industry, is committed to making the Swiss healthcare system fit for the future and, with the “Health Panorama 2024”, is providing the basis for a solution-oriented and fact-based discourse. Interpharma’s statistics publication offers a compact overview of the key facts, figures and developments in relation to the healthcare system, the pharmaceutical market and Switzerland’s position as a pharma hub.
In the 43rd issue of Health Panorama, we provide a compact overview of the key data and developments in relation to the healthcare system, the medication market, patient access and research and development, as well as Switzerland as a pharmaceutical and business hub.
In 2024, Health Panorama once again serves as a contribution to a constructive discussion about the healthcare system, about Switzerland as a business location and about the welfare of patients. The publication Health Panorama – the most important facts and figures on Switzerland’s health and pharmaceutical landscape is available to order or to download as a PDF on the Interpharma website. You can also find key facts and figures – including source references – online and to download in our data center.
René Buholzer, CEO of Interpharma, commented:
“A future-proof healthcare system is not conceived in isolated silos, but rather holistically. Health Panorama makes a fact-based contribution to this social and political discourse.”
Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.
Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.
Information on our key figures and activities in the financial year 2023
Introducing Interpharma
More about the tasks and overriding aims of Interpharma
Contact us
Latest information and media contacts for media representatives